Showing results (81-90 of 96) with videos related to
Sort By:
Pageof 10
European Journal of Medical Research|October 19, 2010
Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patientsC Stephan, H Jaeger, A Carganico, et al.Journal of Virology|November 24, 2017
Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus InfectionHongquan Wan, Li Qi, Jin Gao, et al.Mbio|April 5, 2018
NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?Florian Krammer, Ron A M Fouchier, Maryna C Eichelberger, et al.Infection|March 31, 2010
Safety and efficacy of a saquinavir-containing antiretroviral regimen in previously ART-naïve or pretreated but protease inhibitor-naïve HIV-positive patientsH Knechten, C Stephan, F A Mosthaf, et al.Proceedings of the National Academy of Sciences of the United States of America|December 7, 2011
Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza virusesMatthew R Sandbulte, Kim B Westgeest, Jin Gao, et al.Journal of Medical Virology|January 17, 2002
Clinical evaluation of a single oral dose of human-bovine (UK) reassortant rotavirus vaccines Wa x UK (P1A[8],G6) and Wa x (DS-1 x UK) (P1A[8],G2)Maryna C Eichelberger, Ellen Sperber, Mariam Wagner, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza VaccineJoshua G Petrie, Ryan E Malosh, Caroline K Cheng, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2019
Neutralizing and Neuraminidase Antibodies Correlate With Protection Against Influenza During a Late Season A/H3N2 Outbreak Among Unvaccinated Military RecruitsCarol D Weiss, Wei Wang, Yun Lu, et al.Vaccine|February 11, 2019
Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient populationJoshua G Petrie, Emily T Martin, Rachel Truscon, et al.Mbio|April 11, 2019
Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific AntibodiesJin Gao, Laura Couzens, David F Burke, et al.Pageof 10